Sabah-E-Noor Servaes Selected Research

Catecholamines

1/2017

Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabah-E-Noor Servaes Research Topics

Disease

2	Neuroblastoma 01/2020 - 01/2017
1	Fever (Fevers) 01/2017
1	Infections 01/2017
1	Neutropenia 01/2017
1	Pain (Aches) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Ganglioneuroblastoma 01/2017
1	Hypoxia (Hypoxemia) 01/2017

Drug/Important Bio-Agent (IBA)

2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2017
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2017
2	dinutuximabIBA 01/2020 - 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	temsirolimus FDA Link 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	CatecholaminesIBA 01/2017

Therapy/Procedure

1	Therapeutics 01/2017